A New Destination for Oncology Education
September 15, 2025 | PIONEER, medical education, precision oncology
Medscape Oncology is pleased to announce the launch of a groundbreaking new learning space designed to provide education across tumor types and oncology disciplines: PIONEER – PrecIsion Oncology: Navigating EvidEnce for Real-world impact. This dedicated platform offers comprehensive, structured CME, organizing content by therapeutic target and tumor type to reflect the latest clinical and therapeutic advances. The result is a sharper focus on the science driving treatment decisions, ensuring physicians have the tools to deliver truly personalized care.
“This new learning center is all about providing clinicians with a one-stop destination for structured, consolidated CME, and helping them stay at the forefront of precision oncology to connect more patients with life-changing care. This is a vital resource for clinicians across oncology, and one we’re very proud to provide.” said Zhizhi Fiske, PhD, Director of Clinical Strategy at Medscape Education.
Surveys of Medscape physicians have found that 97% of physicians use biomarker or molecular target information when making treatment decisions. However, 85% of physicians frequently or occasionally encounter challenges in identifying appropriate therapies for patients with actionable mutations. Furthermore, 90% of physicians agree that a cross-tumor, target-based educational program would enhance their clinical decision-making.
“We surveyed over 100 physicians in the U.S. and E.U. The message was clear: doctors are eager to use biomarkers to guide treatment but struggle to keep up with rapid developments. Our findings confirm that while most find existing CME helpful, there is strong demand for interactive biomarker modules, expert panel discussions, and cross-tumor, target-based programs. A recurring theme was the desire for all these resources in one easily accessible place.” said Nabil Dorkhom, MD, Director Clinical Strategy at Medscape Education.
PIONEER is led by a distinguished steering committee of physician experts, including committee chair Fabrice André, MD, PhD, Head of Research, Professor of Oncology, Gustave Roussy, Villejuif, France; Benedikt Westphalen, MD, PhD, Chair, Center for Personalised Medicine,University Hospital, University of Munich, Munich, Germany; Vivek Subbiah, MD, Chief, Early-Phase Drug Development Sarah Cannon Research Institute,Nashville, Tennessee, United States; and Mary Beth Beasley, MD, Professor of Pathology, Head, Thoracic Pathology, Icahn School of Medicine at Mt. Sinai Medical Center, New York, United States.
“Precision oncology is revolutionizing cancer treatment, shifting from broad-spectrum therapies to precisely targeted interventions based on each patient’s unique molecular profile. For healthcare professionals, effective education and readily accessible, centralized information are paramount. This empowers them to harness cutting-edge diagnostics and apply optimized, individualized therapeutic strategies, ultimately improving patient outcomes,” commented committee chair Dr Fabrice André.
Physicians can start learning on the PIONEER microsite here.
Follow us on LinkedIn to stay up to date with the latest news and perspectives
About Medscape Education
Medscape Education is the leading online platform for continuing medical education (CME) and continuing education (CE), trusted by millions of healthcare professionals worldwide. With more than 30 speciality-specific learning destinations, it offers thousands of free, accredited courses for physicians, nurses, pharmacists, and other healthcare professionals. Medscape Education delivers high-impact, evidence-based education designed to support clinical decision-making, improve patient outcomes, and keep healthcare professionals current in a rapidly evolving medical landscape.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Medscape Brings Impact and Data to ESPGHAN
The ESPGHAN Congress in Milan was full of impact as Medscape Education Global presented 5 scientific posters examining the outcomes of their education. The posters detailed the impact Medscape Education...
Empowering Nurses Through Education
Nurse education is powerful and makes an impact.
Pioneering Paths: Women Leadership in Rare Disease
Rare diseases are often thought of as affecting one in 100,000 or one in 1,000,000 people, and that is true for some conditions. But there are many rare diseases that...
TRANSFORMING CME IMPACT: MEDSCAPE’S GAME-CHANGING APPROACH
It’s time for the CME industry to evolve. During recent years, access to data, modern technologies, and methodologies have allowed for deeper analysis of data and a better understanding of...
Why Women in Medicine Should Embrace Social Media
Of course social media has its downside. But online platforms are a powerful tool for women in medicine in terms of forming communities, fighting misinformation, amplifying one another, and galvanizing...
Exceptional Impact Presented at ECCMID 2024
The ECCMID conference in Barcelona, Spain marked the start of Medscape’s publication season in Europe. With three posters being presented at the conference, Medscape shared highlights from the powerful impact...
Showing Deep Expertise at ONS
The Medscape Oncology team will be connecting with the oncology nursing community this week in Washington, DC for the ONS Congress 2024. Medscape Oncology has deep expertise in the oncology...
MEDSCAPE’S NEW AGE OF CERTAINTY FOR CME
The CME industry is changing. More than ever, activities need to be prioritized and measured to increase their impact on patient outcomes. Improving patient outcomes is the core objective for...
Getting Past the Old-Fashioned View of Patient Advocacy
Patient advocacy organizations today are data-driven, doing amazing work — and have the hard evidence to support their impact on patient care. The challenge is getting past the perception of...
Mile High Impact at AAN 2024
The Medscape team will be joining our neurology colleagues in Denver, CO for this year’s AAN Annual Meeting. Impact will take center stage at this year’s event as Medscape presents...